康芝药业(300086)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300086 康芝药业

已收盘 12-12 15:00:00

{"stockData":{"symbol":"300086","market":"SZ","secType":"STK","nameCN":"康芝药业","latestPrice":11.43,"timestamp":1765523001000,"preClose":11.88,"halted":0,"volume":69449211,"delay":0,"changeRate":-0.0379,"floatShares":441000000,"shares":455000000,"eps":-0.4177,"marketStatus":"已收盘","change":-0.45,"latestTime":"12-12 15:00:00","open":11.9,"high":12.07,"low":11.38,"amount":808000000,"amplitude":0.0581,"askPrice":11.44,"askSize":1440,"bidPrice":11.43,"bidSize":3530,"shortable":0,"etf":0,"ttmEps":-0.4177,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":11.88,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":13.07,"lowLimit":10.69,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":455124411,"isCdr":false,"pbRate":5.15,"roa":"--","roe":"--","epsLYR":-0.4737,"committee":0.533256,"marketValue":5202000000,"turnoverRate":0.1576,"status":1,"floatMarketCap":5037000000},"requestUrl":"/m/hq/s/300086","defaultTab":"news","newsList":[{"id":"2590451518","title":"康芝药业：药品及其他产品目前主要以国内销售为主","url":"https://stock-news.laohu8.com/highlight/detail?id=2590451518","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590451518?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:48","pubTimestamp":1765457302,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业(300086)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，请问贵公司有海外市场吗？如果有，具体是哪些业务，哪些国家呢？日本现在流感很严重，贵公司的产品有向日本销售吗？康芝药业回复：您好，公司的药品及其他产品目前主要以国内销售为主，几乎无外销。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100038181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","300086","BK0070","BK0048"],"gpt_icon":0},{"id":"2590960515","title":"康芝药业：宏氏投资已支付1.1亿元履约准备金","url":"https://stock-news.laohu8.com/highlight/detail?id=2590960515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590960515?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:48","pubTimestamp":1765457301,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业(300086)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司股东回购子公司事项进展如何？康芝药业回复：尊敬的投资者，您好！关于宏氏投资的回购方案，公司始终在积极督促推进。目前，宏氏投资已给公司支付1.1亿元履约准备金，后续公司将严格按监管要求，及时按要求披露相关进展。公司通过深交所互动易、投资者热线及创业板指定的信息披露网站披露公司相关信息，敬请谨慎决策，注意投资风险。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121100038180.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0239","300086","BK0070","BK0042"],"gpt_icon":0},{"id":"2590497363","title":"康芝药业完成董事会换届，多项治理制度修订获股东大会通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2590497363","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590497363?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:17","pubTimestamp":1765286224,"startTime":"0","endTime":"0","summary":"中访网数据 康芝药业股份有限公司于2025年12月9日成功召开了2025年第一次临时股东大会。会议审议并通过了公司董事会换届选举及多项治理制度的修订议案。本次会议共有379名股东参与表决，代表股份占公司有表决权股份总数的27.0021%，其中通过网络投票的中小股东371人。新一届董事会的组建及公司治理制度的全面修订与完善，标志着康芝药业在公司治理结构上迈出了重要一步，旨在进一步提升公司规范运作水平和决策效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20251209/31854442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","BK0070","BK0048","BK0042","300086"],"gpt_icon":0},{"id":"2588469380","title":"康芝药业：目前与博鳌先行区没有合作关系","url":"https://stock-news.laohu8.com/highlight/detail?id=2588469380","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588469380?lang=zh_cn&edition=full","pubTime":"2025-12-03 20:49","pubTimestamp":1764766175,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业(300086)12月03日在投资者关系平台上答复投资者关心的问题。投资者提问：“作为乐城先行区首批特许药械代理机构，公司与博鳌先行区是否有合作关系？康芝药业回复：尊敬的投资者，您好！感谢您对公司的关注。目前公司尚未取得海南博鳌乐城国际医疗旅游先行区等相关区域的特许药械代理资质，且目前公司与博鳌先行区没有合作关系。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120300037116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300086","BK0239","BK0042","BK0048","BK0070"],"gpt_icon":0},{"id":"2586024043","title":"康芝药业：目前公司没有辅助生殖业务","url":"https://stock-news.laohu8.com/highlight/detail?id=2586024043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586024043?lang=zh_cn&edition=full","pubTime":"2025-11-27 20:48","pubTimestamp":1764247736,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业(300086)11月27日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司是否有辅助生殖业务?康芝药业回复：尊敬的投资者您好，感谢您对公司的关注！目前公司没有辅助生殖业务！谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700035404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0048","300086","BK0070","BK0239"],"gpt_icon":0},{"id":"2586258864","title":"11月26日康芝药业（300086）龙虎榜数据：机构净买入3326.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586258864","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586258864?lang=zh_cn&edition=full","pubTime":"2025-11-26 17:49","pubTimestamp":1764150584,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月26日公布的交易公开信息显示，康芝药业因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年11月26日收盘，康芝药业报收于12.97元，上涨5.62%，换手率37.56%，成交量165.53万手，成交额21.99亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入3326.63万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600027077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","300086","BK0070","BK0042","BK0239"],"gpt_icon":0},{"id":"2586734426","title":"康芝药业(300086.SZ)：止咳橘红颗粒药物临床试验获批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2586734426","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586734426?lang=zh_cn&edition=full","pubTime":"2025-11-25 17:54","pubTimestamp":1764064455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，康芝药业(300086.SZ)公告，公司申报的“止咳橘红颗粒”获得国家药品监督管理局核准签发的《药物临床试验批准通知书》。在进一步完善临床试验方案的基础上，同意止咳橘红颗粒开展用于慢性阻塞性肺疾病急性发作期(痰热壅肺证)的临床试验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1373367.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"康芝药业(300086.SZ)：止咳橘红颗粒药物临床试验获批准","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0070","BK0048","BK0042","300086"],"gpt_icon":0},{"id":"2585468711","title":"康芝药业（300086）披露召开2025年第一次临时股东大会通知，11月24日股价下跌6.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585468711","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585468711?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:58","pubTimestamp":1763978328,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，康芝药业报收于10.85元，较前一交易日下跌6.63%，最新总市值为49.38亿元。该股当日开盘11.53元，最高12.41元，最低10.71元，成交额达12.52亿元，换手率为25.19%。公司近日发布公告称，将于2025年12月9日在海口召开2025年第一次临时股东大会，会议采取现场与网络投票结合方式。股权登记日为2025年12月3日。会议将审议董事会换届选举非独立董事和独立董事候选人、修订公司章程、修订及制定多项公司治理制度等议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400023399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0239","BK0070","300086","BK0042"],"gpt_icon":0},{"id":"2584312671","title":"康芝药业：药品涵盖止咳退热抗生素类别","url":"https://stock-news.laohu8.com/highlight/detail?id=2584312671","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584312671?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:51","pubTimestamp":1763643091,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业(300086)11月19日在投资者关系平台上答复投资者关心的问题。投资者提问：每年12月到1月是流感爆发期，请问贵司旗下有哪些应对流感的相关药物？谢谢康芝药业回复：您好，感谢您对公司的关注！流感患者主要表现为突然的高热，常有咳嗽、咽喉痛、鼻塞、流涕等呼吸道症状，伴有头痛、肌肉酸痛等全身不适，有的会发生胃肠道的不适感。针对流感相关症状来看，公司药品涵盖了止咳、退热、抗生素、消化系统等类别。公司详细的产品信息请见公司2025年半年度报告。谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000035568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300086","BK0239","BK0070","BK0048","BK0042"],"gpt_icon":0},{"id":"2584955545","title":"康芝药业（300086）披露关于公司股价异动的公告，11月18日股价上涨6.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584955545","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584955545?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:27","pubTimestamp":1763476043,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，康芝药业报收于11.81元，较前一交易日上涨6.3%，最新总市值为53.75亿元。该股当日开盘11.11元，最高12.82元，最低10.92元，成交额达17.58亿元，换手率为33.27%。公司于近日披露《关于公司股价异动的公告》，称其股票于2025年11月14日、17日、18日连续三个交易日收盘价涨幅偏离值累计超过30%，构成异常波动。公告显示，公司2024年度净利润亏损21,620.85万元，2025年前三季度净利润亏损9,661.15万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800039985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0048","BK0042","BK0239","300086"],"gpt_icon":0},{"id":"2584933923","title":"11月18日康芝药业（300086）龙虎榜数据：机构净买入2553.51万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2584933923","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584933923?lang=zh_cn&edition=full","pubTime":"2025-11-18 17:58","pubTimestamp":1763459930,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月18日公布的交易公开信息显示，康芝药业因连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年11月18日收盘，康芝药业报收于11.81元，上涨6.3%，换手率33.27%，成交量146.6万手，成交额17.58亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入2553.51万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111800027889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","300086","BK0042","BK0070","BK0239"],"gpt_icon":0},{"id":"2583579041","title":"11月14日康芝药业（300086）龙虎榜数据：机构净买入9185.37万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2583579041","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583579041?lang=zh_cn&edition=full","pubTime":"2025-11-14 17:33","pubTimestamp":1763112797,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年11月14日公布的交易公开信息显示，康芝药业因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年11月14日收盘，康芝药业报收于10.62元，上涨20.0%，涨停，换手率28.34%，成交量124.88万手，成交额12.42亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入9185.37万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400028273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","300086","BK0048","BK0070"],"gpt_icon":0},{"id":"2583547821","title":"异动快报：康芝药业（300086）11月14日10点16分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2583547821","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583547821?lang=zh_cn&edition=full","pubTime":"2025-11-14 10:20","pubTimestamp":1763086831,"startTime":"0","endTime":"0","summary":"证券之星11月14日盘中消息，10点16分康芝药业触及涨停板。目前价格10.49，上涨18.53%。其所属行业化学制药目前上涨。该股为海南概念，海南自由贸易港，自由贸易港概念热股，当日海南概念概念上涨4.85%，海南自由贸易港概念上涨4.05%，自由贸易港概念上涨2.04%。11月13日的资金流向数据方面，主力资金净流出2549.66万元，占总成交额4.46%，游资资金净流出311.36万元，占总成交额0.54%，散户资金净流入2861.02万元，占总成交额5.01%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400010316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300086","BK0239","BK0070","BK0048","BK0042"],"gpt_icon":0},{"id":"2581098951","title":"康芝药业：聚焦主业优化产品结构","url":"https://stock-news.laohu8.com/highlight/detail?id=2581098951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581098951?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:48","pubTimestamp":1762433302,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业11月05日在投资者关系平台上答复投资者关心的问题。谢谢康芝药业回复：尊敬的投资者，您好！应对当前局面，我们的核心策略是：聚焦主业，通过优化产品结构、拓展电商与连锁药店渠道实现儿童药及重点单品销售突破、加强市场渗透扩大份额、盘活低效资产强化业财融合、深化科研合作加速创新药研发等多各种措施，以扎实经营稳定市场预期。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110600036160.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0070","BK0239","300086","BK0048"],"gpt_icon":0},{"id":"2580233183","title":"股市必读：康芝药业（300086）登10月31日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2580233183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580233183?lang=zh_cn&edition=full","pubTime":"2025-11-03 03:03","pubTimestamp":1762110194,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，康芝药业报收于8.74元，上涨17.47%，换手率33.61%，成交量148.13万手，成交额12.18亿元。当日关注点来自交易信息汇总：10月31日主力资金净流入2548.98万元，游资资金净流出8725.26万元，散户资金净流入6176.28万元。来自龙虎榜上榜：康芝药业因日换手率达到30%的前5只证券于10月31日登龙虎榜，近5个交易日内第2次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300000648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0070","BK0042","300086","BK0239"],"gpt_icon":0},{"id":"2579464145","title":"康芝药业：目前自贸港相关政策对公司影响较少","url":"https://stock-news.laohu8.com/highlight/detail?id=2579464145","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579464145?lang=zh_cn&edition=full","pubTime":"2025-10-31 20:48","pubTimestamp":1761914907,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业(300086)10月30日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘能不能回复下？海南自贸港封关在即，请问贵公司在海南自贸港建设相关领域有哪里布局，医药及大健康业务是否会受益？未来中药国际市场规模有多大，贵公司将如何加速中药国际化布局？康芝药业回复：尊敬的投资者，您好！目前公司产品以内销为主，目前自贸港相关政策对公司影响较少。公司暂时没有中药国际市场规模预测的相关数据,将依照法规要求及时履行相关信息披露义务。感谢关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100047040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0048","BK0070","300086","BK0239"],"gpt_icon":0},{"id":"2579464483","title":"康芝药业：暂停苏拉明钠临床入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2579464483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579464483?lang=zh_cn&edition=full","pubTime":"2025-10-31 20:48","pubTimestamp":1761914906,"startTime":"0","endTime":"0","summary":"证券之星消息，康芝药业10月30日在投资者关系平台上答复投资者关心的问题。公司关于苏拉明钠对利尿剂抵抗的急性肾损伤适应症研究，鉴于有临床试验显示苏拉明钠在对利尿剂抵抗的急性肾损伤适应症上未观察到统计学显著获益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100047038.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0070","BK0239","300086","BK0048"],"gpt_icon":0},{"id":"2579545824","title":"10月31日康芝药业（300086）龙虎榜数据：机构净买入7379.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579545824","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579545824?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:46","pubTimestamp":1761904018,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年10月31日公布的交易公开信息显示，康芝药业因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2025年10月31日收盘，康芝药业报收于8.74元，上涨17.47%，换手率33.61%，成交量148.13万手，成交额12.18亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入7379.06万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100037717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0070","BK0042","300086","BK0239"],"gpt_icon":0},{"id":"2579780749","title":"10月29日康芝药业（300086）龙虎榜数据：机构净买入7643.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579780749","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579780749?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:43","pubTimestamp":1761731035,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2025年10月29日公布的交易公开信息显示，康芝药业因日涨幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2025年10月29日收盘，康芝药业报收于8.07元，上涨15.95%，换手率32.87%，成交量144.84万手，成交额11.51亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入7643.02万元。从龙虎榜数据可以发现和研究机构、游资和散户的资金动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900037090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0048","300086","BK0070","BK0239"],"gpt_icon":0},{"id":"2579228943","title":"异动快报：康芝药业（300086）10月29日10点4分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2579228943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579228943?lang=zh_cn&edition=full","pubTime":"2025-10-29 10:05","pubTimestamp":1761703536,"startTime":"0","endTime":"0","summary":"证券之星10月29日盘中消息，10点4分康芝药业触及涨停板。目前价格8.34，上涨19.83%。其所属行业化学制药目前下跌。该股为海南概念，海南自由贸易港，自由贸易港概念热股，当日海南概念概念上涨4.76%，海南自由贸易港概念上涨3.95%，自由贸易港概念上涨1.42%。10月28日的资金流向数据方面，主力资金净流入973.98万元，占总成交额5.02%，游资资金净流出866.25万元，占总成交额4.46%，散户资金净流出107.74万元，占总成交额0.56%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900016719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0048","BK0070","BK0042","300086","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765535634854,"stockEarnings":[{"period":"1week","weight":0.079},{"period":"1month","weight":0.3687},{"period":"3month","weight":0.7394},{"period":"6month","weight":1.2715},{"period":"1year","weight":0.9507},{"period":"ytd","weight":1.4245}],"compareEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":-0.0323},{"period":"3month","weight":0.0007},{"period":"6month","weight":0.147},{"period":"1year","weight":0.1284},{"period":"ytd","weight":0.1556}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"康芝药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"41838人(较上一季度增加31.29%)","perCapita":"10533股","listingDate":"2010-05-26","address":"海南省海口市秀英区国家高新技术产业开发区药谷工业园药谷三路6号","registeredCapital":"45512万元","survey":"　　康芝药业股份有限公司的主营业务是儿童用药、母婴健康用品的研发、生产和销售。公司的主要产品是儿童药、母婴健康用品。爱护曾获得“广东省省级企业技术中心”、“广东省名牌产品”、“行业优秀企业”、“2024CBE美妆好品牌”等荣誉，为母婴人群提供经权威认证的、安全可靠的、健康的产品及专业服务。","listedPrice":60},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"康芝药业(300086)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供康芝药业(300086)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"康芝药业,300086,康芝药业股票,康芝药业股票老虎,康芝药业股票老虎国际,康芝药业行情,康芝药业股票行情,康芝药业股价,康芝药业股市,康芝药业股票价格,康芝药业股票交易,康芝药业股票购买,康芝药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"康芝药业(300086)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供康芝药业(300086)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}